<i>TET2</i> truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm-Reference-Cited by-同舟云学术

TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm

Published:2023-05-11 Issue:10 Volume:7 Page:2000-2003
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Beird Hannah¹^ORCID,Yin C. Cameron²^ORCID,Khoury Joseph D.²^ORCID,Pierce Sherry³,Abbas Hussein A.¹³^ORCID,Zhao Li¹,Skwarska Anna³^ORCID,Qazilbash Muzaffar⁴,Konopleva Marina³^ORCID,Futreal P. Andrew¹,Pemmaraju Naveen²^ORCID

Affiliation:

1. 1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX

2. 2Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX

3. 3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

4. 4Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/10/2000/2052274/blooda_adv-2022-007879-main.pdf

Reference31 articles.

1. Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm;Guru Murthy;Leuk Res,2018

2. Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment;Sweet;Curr Opin Hematol,2020

3. Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm;Pemmaraju;Blood,2021

4. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark;Taylor;Blood,2019

5. Sex-Biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis;Togami;Cancer Discov,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicle-derived miRNA-mediated cell-cell communication inference for single-cell transcriptomic data with miRTalk;2024-07-10

2. Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival;Blood Advances;2024-05-31

3. Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature;Cancer;2024-04-15

4. Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis;Blood Cancer Journal;2023-08-09

5. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report;2023-05-15